NYSE:DGX
Quest Diagnostics Inc.
Quest Diagnostics Inc.'s revenue grew 11.8% in fiscal 2025 to $11.0B while operating margin rose to 14.1%. Free cash flow was $1.4B, 12.3% of revenue.Summary generated from Quest Diagnostics Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$11.0B
Revenue growth+11.8%
Revenue, 5-yr CAGR+3.2%
Gross margin33.2%
Operating margin14.1%
Net margin9.0%
ROIC9.5%
Return on equity14.2%
Debt / equity0.79
Free cash flow$1.4B
FCF margin12.3%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10.8 | 9.9 | 9.3 | 9.9 | 11.0 |
| Operating income | 2.4 | 1.4 | 1.3 | 1.3 | 1.6 |
| Net income | 2.0 | 0.9 | 0.9 | 0.9 | 1.0 |
| Free cash flow | 1.8 | 1.3 | 0.9 | 0.9 | 1.4 |
Recent filings
- 8-KDirector or officer change
Oct 6, 2026 - 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Sep 3, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 23, 2026 - 8-KResults of operations and financial condition
Jul 23, 2026 - 8-KResults of a shareholder vote
May 21, 2026 - 8-KEntry into a material agreement
May 8, 2026 - 8-KOther events
May 1, 2026